ImmuniCell® in Patients With Advanced Cancers

Clinical trial NCT02459067 · TERMINATED

Trial details

NCT number: NCT02459067
Sponsor: TC Biopharm
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma Non-small Cell Lung Cancer Renal Cell Cancer

Start date: 2015-12-01
Primary completion: 2018-11-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.